Adjust Font Increase Font Decrease Font
  • Email
  • Print
  • RSS Feed

Media Releases

Statement to Physician Payments Sunshine Act Final Rule
WASHINGTON, D.C. (February 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today: “PhRMA is currently reviewing the final regulation of the Physician Payments Sunshine Act and looks forward to seeing how CMS addressed key concerns that were previously raised. PhRMA remains committed to the principles of the Sunshine Act and continues to believe that careful implementation is essential to ensuring that Sunshine fulfills its objective of usable, transparent, and understandable sharing of information.” About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research and biotechnology companies...
Read more

Latest Releases

Nearly 1,000 Medicines in Development to Help Patients in Their Fight Against Cancer
5/30/2012
America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). These potential medicines, which are either in clinical trials or under review by the Food and Drug Administration, include 121 for lung cancer, 117 for lymphoma and 111 for breast cancer.
More
PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization
5/24/2012
More
PhRMA Applauds G8 Action on Anti-Counterfeiting
5/19/2012
PhRMA President and CEO John Castellani issued the following statement today concerning G8 Action on Anti-Counterfeiting. “PhRMA is pleased that the G8 Leaders recognize the threat to global public health of counterfeiting activities around the world. We applaud the leaders’ recognition that counterfeiting must be addressed."
More
New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5/16/2012
More
PhRMA Urges President Obama to Secure an Ambitious Trans-Pacific Partnership Agreement
5/8/2012
More
PhRMA Statement on Special 301 Report
5/2/2012
The Pharmaceutical Research and Manufacturers of America (PhRMA) released the following statement today on the Special 301 Report issued by the United States Trade Representative (USTR).
More

Subscribe to our Email Updates